3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Phase 3
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Classical hematology
1
Conditions
Anemia
6
Colorectal Neoplasms
3
Postoperative Complications
2
Anemia, Iron-Deficiency
2
Adenocarcinoma
2
Stomach Neoplasms
1
Neoplasms
1
Lymphoproliferative Disorders
1
Interventions
ferric carboxymaltose
1
Brentuximab Vedotin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Lymphoproliferative Disorders
×
ferric carboxymaltose
×
Clear all
NCT01100879
2022-05-09
AOC-MM
Vifor Pharma
Phase 4
Terminated
3 enrolled